The fish oil medication lowers triglycerides in the blood and prevents heart attacks.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has obtained US Food and Drug Administration (FDA) approval for its generic version of Lovaza, a fish oil medication for lowering triglycerides in the blood. Teva will begin shipping immediately.
Brand Lovaza, sold by GlaxoSmithKline plc (NYSE; LSE: GSK), had $1.1 billion in US sales in 2013.
Published by Globes [online], Israel business news - www.globes-online.com - on April 8, 2014
© Copyright of Globes Publisher Itonut (1983) Ltd. 2014